Sort
21,453 grants matching “tuberculosis”
Macaque Models of AIDS-Related Tuberculosis and T Cell
$797,033Zheng W Chen · University Of Illinois At Chicago · R01 · FY2008 · HL
Dual Targeting of Mtb Resistance Mechanisms
$796,912Christoph Grundner · Seattle Children'S Hospital · R01 · FY2023 · AI
Human Genetic determinants of HBV recovery
$796,842David L Thomas · Johns Hopkins University · R01 · FY2022 · AI
Project 1: Transmission Biology of M. tuberculosis: Genes Required to Survive Stressful Transitions
$796,764Carl F Nathan · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions.
$796,700David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$796,698Charles W. Flexner · Johns Hopkins University · R24 · FY2024 · AI
Translational studies of hookworm infection in Ghana
$796,540Michael Cappello · Yale University · R01 · FY2022 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$796,534Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Population Based Molecular epidemiology of Tuberculosis
$796,206Philip C Hopewell · University Of California, San Francisco · R01 · FY2007 · AI
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment
$795,819Sara Tartof · Kaiser Foundation Research Institute · R01 · FY2022 · AI
Hypoxia, tuberculosis, and T cell dysfunction
$795,775Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Novel mycobacterial translocase I inhibitors - a new class of anti-TB drugs
$795,701Venkata M Reddy · Sequella, Inc. · R44 · FY2009 · AI
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$795,484Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$795,335Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$795,262Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Longtitudinal Studies of HIV-Associated Bacterial Pneumonia
$795,244William N Rom · New York University School Of Medicine · R01 · FY2011 · HL
Phase I Trial for TB Therapeutics - VTEU
$795,222Emmanuel B Walter · Duke University · N01 · FY2015 · AI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR
$795,192Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2023 · AI
A Preclinical Program for Targeting Mycobacterium tuberculosis KasA
$795,178Joel Stephen Freundlich · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Immune Control and Evasion during Acute HCV Infection
$795,032Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2014 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$794,603Mark Hatherill · University Of Cape Town · R01 · FY2023 · AI
HARLEM AIDS TREATMENT GROUP-'CPCRA'
$794,459Wafaa M. El-Sadr · Columbia University Health Sciences · U01 · FY2006 · AI
Target based discovery of next generation pyrazinamide
$794,409Veronique Dartois · Hackensack University Medical Center · R01 · FY2021 · AI
U of Colorado Center for AIDS Research
$794,362Thomas B Campbell · University Of Colorado Denver · P30 · FY2008 · AI
Adjuvants for Skin Immunization: Discovery and Mechanisms
$794,321Ioanna Skountzou · Emory University · R01 · FY2014 · AI